Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Am J Transplant. 2020 Dec;20(12):3401-3412. doi: 10.1111/ajt.15884. Epub 2020 Apr 15.
We evaluated the hypothesis that grafts from donors with high muscle mass and quality may have a better outcome after living-donor-liver-transplantation (LDLT) than those from usual donors. A total of 376 primary adult-to-adult LDLT cases were enrolled in this study. Donor skeletal muscle mass index (SMI) and intramuscular adipose tissue content (IMAC) were used as markers of muscle mass and quality. In male donor cases (n = 198), those with higher SMI and lower IMAC than age-adjusted values were defined as the "high muscularity donors" (n = 38) and the others were defined as the "control" (n = 160). The high muscularity donor showed better 1-year (97% vs 82%, P = .020) and overall graft survival rate (88% vs 67%, P = .024) than the control group after LDLT. Contrastingly, the influence of the muscularity was not observed in female donor cases. Multivariable analysis including donor age confirmed that a high muscularity donor was an independent protective factor for overall graft survival after LDLT (hazard ratio, 0.337; 95% CI: 0.101-0.838; P = .017). Our study first confirmed that high muscle mass and quality of a male donor is a protective factor of allograft loss after LDLT, independently from donor age.
我们评估了以下假设,即与常规供体相比,肌肉质量和肌肉质量高的供体的移植物在活体肝移植(LDLT)后可能会有更好的结果。本研究共纳入 376 例成人对成人 LDLT 原发性病例。供体骨骼肌质量指数(SMI)和肌内脂肪组织含量(IMAC)用作肌肉质量和肌肉质量的标志物。在男性供体病例(n=198)中,将 SMI 较高且 IMAC 低于年龄校正值的供体定义为“高肌肉供体”(n=38),其他供体定义为“对照组”(n=160)。与对照组相比,高肌肉供体在 LDLT 后 1 年(97%比 82%,P=0.020)和整体移植物存活率(88%比 67%,P=0.024)更高。相反,在女性供体病例中未观察到肌肉量的影响。包括供体年龄在内的多变量分析证实,高肌肉供体是 LDLT 后整体移植物存活率的独立保护因素(危险比,0.337;95%CI:0.101-0.838;P=0.017)。我们的研究首次证实,男性供体的高肌肉质量和肌肉质量是 LDLT 后同种异体移植物丢失的保护因素,与供体年龄无关。